Type 2 & other diabetes

Differences in Continuous Glucose Monitoring Metrics Between Prediabetes and Normoglycemia: A Systematic Review and Meta-Analysis

J Diabetes Sci TechnolPublished Systematic review and meta-analysis

Pooled result · MAGEResult — go to the resultMD 9.41 mg/dL 95% CI 4.31–15.31

Authors' conclusion

These results provide the first quantitative evidence that CGM can discriminate between prediabetes and normoglycemia, supporting its potential as a complementary tool for refined metabolic risk assessment. Further prospective studies are needed to determine its predictive value for progression to T2DM.

Study context

Population
Individuals with prediabetes vs normoglycemia; PubMed, EMBASE and CENTRAL searched from inception to September 3, 202510 studies in quantitative synthesis
Participants
1,657 individuals
Comparison
Prediabetes vs normoglycemia
Outcome
Mean amplitude of glycemic excursions (MAGE)
Methodological details16 studies met inclusion criteria; 10 in quantitative synthesis
  • 16 studies met inclusion criteria; 10 in quantitative synthesis

Pooled result

MAGE

MD

9.41 mg/dL

95% CI 4.31–15.31

Prediabetesvs Normoglycemia
MD 9.41 mg/dL (95% CI 4.31–15.31)

As reported in the abstract

Further pooled results

OutcomeMD (%) (95% CI)
TAR%5.68 (1.04–10.32)
OutcomeMD (mg/dL) (CI)
24-hour mean glucose7.91 (6.27–9.55)

Original publication

Differences in Continuous Glucose Monitoring Metrics Between Prediabetes and Normoglycemia: A Systematic Review and Meta-Analysis. J Diabetes Sci Technol. Published 3 March 2026. doi:10.1177/19322968261426384

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.